Cleaning Validation (MACO) Calculator
How to use: Enter Product A (cleaned away) and Product B (next product) parameters. The calculator computes MACO by all four methods, selects the most conservative, and derives swab, rinse, and surface acceptance criteria.
Product Pair Preset
Product A (Being Cleaned Away)
Min. Therapeutic Daily Dose (mg) ?
LD50 (oral, rat) (mg/kg) ?
PDE/HBEL (mg/day) ?
Product B (Next Product)
Min. Batch Size (kg) ?
Max. Daily Dose (mg/day) ?
Equipment & Sampling
Equipment Surface (cm2) ?
Swab Area (cm2) ?
Final Rinse Vol. (L) ?
Safety Factor ?
Body Weight (kg) ?
0.00
mg Recommended MACO
Most conservative method
Acceptance Criteria
--
Swab Limit (µg/swab)
--
Rinse Limit (µg/mL)
--
Surface (µg/cm2)
MACO by Method
Method Comparison
Validation Report
Method MACO (mg) Swab (µg/swab) Rinse (µg/mL) Surface (µg/cm2) Status

About Cleaning Validation and MACO Calculations

Cleaning validation ensures that shared pharmaceutical manufacturing equipment is free from residues of previously manufactured products before the next batch. The Maximum Allowable Carryover (MACO) is the cornerstone of cleaning validation acceptance criteria, defining the maximum amount of product residue (in mg) that can safely be present without posing a risk to the patient receiving the next product. This cleaning validation calculator computes MACO using all four industry-standard methods and automatically selects the most conservative value as the recommended acceptance criterion.

The dose-based method (1/1000th of the minimum therapeutic dose) has been the traditional approach since the 1990s, while the LD50-based method uses lethal dose data to derive a No Observed Effect Level (NOEL). The 10 ppm default method provides a simple concentration-based criterion. The PDE/HBEL method, mandated by the EMA 2014 guideline for all new cleaning validation studies, uses toxicologically derived health-based exposure limits and is now considered the regulatory standard. For highly potent active pharmaceutical ingredients (HPAPIs), the PDE/HBEL method is mandatory because the traditional 1/1000th dose approach may not provide adequate patient protection.

From the recommended MACO, three practical acceptance limits are derived: the swab limit (µg per swab area, typically 25 cm2), the rinse limit (µg/mL of final rinse solution), and the surface residue limit (µg/cm2). These limits must be above the analytical method's limit of quantitation (LOQ) to be practically measurable. The method validation calculator can help verify that your analytical method's LOD and LOQ meet these requirements. Cleaning validation is closely linked to GMP manufacturing quality systems and is a top-5 FDA 483 observation category.

Further reading

Related Articles

Cleaning Validation for Biopharmaceutical Manufacturing
Complete guide to GMP cleaning validation including MACO, acceptance criteria, and regulatory expectations.
FDA Process Validation for Biologics (Stages 1-3)
Comprehensive FDA validation framework including cleaning and equipment qualification.
CIP/SIP Validation for Biopharmaceutical Equipment
Validated CIP cycles, rinse sampling, and equipment qualification protocols.
CPP/CQA Mapping and Design Space
Quality by Design (QbD) framework for process parameter control and risk assessment.

Frequently Asked Questions

What is MACO in cleaning validation?

MACO (Maximum Allowable Carryover) is the maximum amount of residue from a previously manufactured product that can be safely present in the next product manufactured on the same equipment. It is expressed in milligrams and serves as the basis for calculating swab acceptance limits, rinse limits, and surface residue limits used in GMP cleaning validation.

How is MACO calculated using the dose-based method?

The dose-based MACO formula is: MACO = (TDDA x MBSB) / (SF x MDDB), where TDDA is the minimum therapeutic daily dose of Product A (the product being cleaned away), MBSB is the minimum batch size of the next product (Product B), SF is the safety factor (typically 1000), and MDDB is the maximum daily dose of Product B. This ensures that no more than 1/1000th of the therapeutic dose of Product A could be present in a dose of Product B.

What is the difference between MACO and PDE/HBEL?

MACO is the final carryover limit in mg that accounts for batch size and dosing. PDE (Permitted Daily Exposure) or HBEL (Health-Based Exposure Limit) is the toxicologically derived daily intake limit in mg/day for a specific substance. PDE is calculated from NOAEL data using safety factors for species, inter-individual variability, study duration, severity, and LOAEL extrapolation. MACO from PDE = (PDE x MBSB) / MDDB. The EMA 2014 guideline mandates PDE/HBEL-based limits for all new cleaning validation studies.

How do I calculate swab and rinse acceptance limits from MACO?

Swab limit = (MACO x swab area) / total equipment surface area. For a standard 25 cm2 swab: Swab limit (µg/swab) = (MACO in mg x 1000 x 25) / total surface area (cm2). Rinse limit = MACO / final rinse volume. For example, if MACO = 5 mg and rinse volume = 500 L: Rinse limit = 5 mg / 500 L = 0.01 mg/L = 10 µg/L. Always verify that these limits are above the analytical method's LOQ.

Which MACO method should I use for cleaning validation?

Current regulatory expectations (EMA 2014, EU GMP Annex 15) require PDE/HBEL-based limits for all new cleaning validation studies. However, the traditional dose-based (1/1000th dose), LD50-based, and 10 ppm methods should also be calculated, and the most conservative (lowest MACO) should be used as the acceptance criterion. For highly potent compounds (HPAPI), the PDE/HBEL method is mandatory. Many facilities calculate all four methods and select the lowest value.

What safety factors are used in PDE calculation?

PDE = NOAEL / (F1 x F2 x F3 x F4 x F5). F1 accounts for species extrapolation (1-12 depending on species), F2 for inter-individual variability (typically 10), F3 for study duration (1-10, shorter studies get higher factors), F4 for severity of the critical effect (1-10), and F5 for LOAEL-to-NOAEL extrapolation (1-10, used when no NOAEL is available). The resulting PDE is in mg/day and represents the dose unlikely to cause adverse effects over a lifetime of daily exposure.